After spending time with the Tampa Bay Buccaneers in the spring and summer, I came away thinking they would be a Super Bowl contender. Now I am convinced of it. The Bucs have navigated through a ...

Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combinations As of 2023, ...

An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...

Johnson & Johnson has agreed a $850 million deal to acquire Proteologix that will give it a pair of early-stage bispecific antibodies with immunology applications, including a drug heading for phase 1 ...